Jetema Co

Jetema Co FCF/Debt

The Free Cash Flow to Debt Ratio of Jetema Co (216080.KQ) as of Oct 16, 2026 is -9.58 %. In the previous year, Free Cash Flow to Debt Ratio was -4.26 % — a change of 124.72% (lower).

FCF/Debt

-9.58 %

YoY

124.72%

Last updated:

Free Cash Flow to Debt Ratio of Jetema Co is 2025 -9.58 % . Free Cash Flow to Debt Ratio of Jetema Co was 2024 -4.26 % . It decreases by 124.72% lower compared to the previous year.

The Jetema Co FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2018
-100.08 KRW
Jan 1, 2019
-143.86 KRW
Jan 1, 2020
-9.60 KRW
Jan 1, 2021
-17.62 KRW
Jan 1, 2022
-46.38 KRW
Jan 1, 2023
-0.27 KRW
Jan 1, 2024
-4.26 KRW
Jan 1, 2025
-9.58 KRW
The Jetema Co FCF/Debt history
YEARFCF/DebtYoY
-9.58 %+124.72%
-4.26 %+1,500.48%
-0.27 %-99.43%
-46.38 %+163.17%
-17.62 %+83.59%
-9.60 %-93.33%
-143.86 %+43.74%
-100.08 %+14.89%
-87.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jetema Co Stock analysis

What does Jetema Co do? Jetema Co Ltd is a South Korean company based in Wonju, Gangwon-Do, operating within the Health Care sector, specifically in the Pharmaceuticals industry. The company focuses on the manufacturing and distribution of aesthetic medical products, including dermal fillers, threads, botulinum toxin, and other medical devices. Jetema Co Ltd went public on November 14, 2019, with its stock listed under the ticker 216080.KQ and ISIN KR7216080002. The company currently employs 187 full-time staff members. Jetema's product portfolio includes hyaluronic acid fillers designed for facial beauty treatments, as well as medical devices aimed at improving wrinkles, facial contours, and volume. Additionally, the company produces laser equipment for treating conditions such as leukoplakia, psoriasis, and alopecia areata, along with lifting medical devices, cosmetic mask packs, and pharmaceutical excipients. The company's website is www.jetema.com. Jetema Co Ltd is engaged in the development, manufacturing, and distribution of its products, with a focus on aesthetic and medical applications. The company does not disclose further details on its financial performance, acquisitions, or specific product names beyond what is publicly available. It operates primarily in South Korea, serving both domestic and international markets through its product offerings. Jetema Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jetema Co stock

Free Cash Flow to Debt Ratio of Jetema Co is -9.58 % in 2025.

Free Cash Flow to Debt Ratio of Jetema Co changed from -4.26 % to -9.58 %, representing a 124.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Jetema Co since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Jetema Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Jetema Co

All Key Metrics — Jetema Co